DAIC

SEPTEMBER 10, 2024

This study highlights the power of our cell mimic platform in driving next-generation tests that could enhance patient care." Clinicians need better tools to guide decision making on the choice of antiplatelet therapy in coronary artery disease patients, particularly after coronary stenting.

Thrombosis 52

Thrombosis Coronary Artery Disease Innovation Stent 52

Journal of the American Heart Association

DECEMBER 24, 2024

They hold the promise of revolutionizing patient care. Improved recognition of biomarker research and a greater emphasis on mechanistic evidence can better equip clinicians to deal with the uncertainty that defines the practice of thrombosis medicine.

Biomarkers 45

Biomarkers Thrombosis Research Innovation 45

DAIC

JUNE 12, 2024

It enrolled 162 subjects at 30 centers with three patient populations – non-thrombotic iliac vein lesion (NIVL), post-thrombotic syndrome (PTS) and acute deep vein thrombosis (aDVT). Current and future burden of venous thrombosis: Not simply predictable. Regulatory disclosures Developed by Vesper Medical, Inc. ,

Stent 105

Stent Stents Anatomy Ultrasound 105

Frontiers in Cardiovascular Medicine

JANUARY 29, 2025

For younger or thrombophilic patients, careful evaluation of the filter's suitability and extended follow-up are crucial to optimize outcomes.

Thrombosis 52

Thrombosis Embolism Stent Stents 52

DAIC

FEBRUARY 18, 2025

The dataset suggests tracking clinic-reported outcome measures at six months within the first year after diagnosis and annually thereafter, and patient-reported outcomes annually, with more frequent tracking advised for patients who undergo either a surgical or transcatheter procedure.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

Cardiometabolic Health Congress

AUGUST 23, 2024

The Dyslipidemia/Atherosclerosis/Thrombosis track will feature sessions on dyslipidemia and LDL cholesterol, including: LDL Lowering Therapy Beyond Statins Supported by an educational grant from Esperion Therapeutics.

Dementia 52

Dementia Cholesterol Risk Factors CME 52

DAIC

MAY 7, 2024

“Evaluating care disparities in real clinical practices is key to addressing the existing barrier and improving patient outcomes,” Parikh added. About Pulmonary Embolism PE is often caused by blood clots in the legs, otherwise known as deep vein thrombosis, that travel through the veins and into the lungs.

Embolism 122

Embolism Pulmonary Blood Clot Interventional Cardiology 122